Session Details
[P1]Poster Presentations (Odd No.)
Tue. Jul 7, 2026 2:10 PM - 3:10 PM JST
Tue. Jul 7, 2026 5:10 AM - 6:10 AM UTC
Tue. Jul 7, 2026 5:10 AM - 6:10 AM UTC
Poster Session( Ito International Research Center B2)
[P-01]Single-Cell Multi-Omics Analysis Reveals a Potential Role of ZEB2+ ThA Cells in Systemic Lupus Erythematosus Pathogenesis
*Hiroyuki Teruya1, Toshiyuki Ushijima1, Manaka Goto1,2, Hideyuki Takahashi1, Takahiro Itamiya1, Hirofumi Shoda3, Haruka Tsuchiya1, Mineto Ota1, Tomohisa Okamura1,2, Keishi Fujio1 (1. Department of Allergy and Rheumatology, the University of Tokyo (Japan), 2. Department of Functional Genomics and Immunological Diseases, Graduate School of Medicine (Japan), 3. Department of Rheumatology, Tokyo Medical University Hospital (Japan))
[P-03]A Novel Player in Immune Aging: Senescence-Prone Immune Cell Subsets (SPICs)
*Yuki T. Okamura1, Teh-Wei Wang2, Makoto Nakanishi1 (1. Division of Cancer Cell Biology, Institute of Medical Science, The University of Tokyo (Japan), 2. Project Division of Generative AI Utilization Aging Cells, Institute of Medical Science, The University of Tokyo (Japan))
[P-05]Functional analysis of accessory protein ORF4 in human coronavirus 229E
*Aikeda Aishajiang1, Yuki Kitai1, Miyuki Kawase2, Kazuya Shirato2, Shohei Kojima3, Yuri Furusawa4, Yukiko Akahori1, Hiroshi Katoh1, Hidekazu Nishimura5, Yoshihiro Kawaoka6, Makoto Takeda1 (1. Graduate School of Medicine and Faculty of Medicine, The University of Tokyo (Japan), 2. National Institute of Infectious Diseases, Japan Institute for Health Security (Japan), 3. WPI-Bio2Q, Keio University (Japan), 4. RIKEN Center for Integrative Medical Sciences (Japan), 5. Virus Research Center, Clinical Research Division, Sendai Medical Center (Japan), 6. The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (Japan))
[P-07]TRPV4-mediated calcium influx governs temperature-dependent SARS-CoV-2 replication
*Takeshi Ichinohe1 (1. Institute of Medical Science, The University of Tokyo (Japan))
[P-09]Development of novel self-amplifying RNAs for vaccine modality
*Ryo Komorizono1, Yuki Furuse1 (1. Department of Microbiology and Infection, The UTOPIA Center, The University of Tokyo (Japan))
[P-11]The herpes simplex virus 1 Us3 activation loop regulates phosphorylation across the substrate repertoire and neurovirulence.
*Saori Shio1, Akihisa Kato1, Shaocong Liu1, Yuhei Maruzuru1, Yasushi Kawaguchi1 (1. DIVISION OF MOLECULAR VIROLOGY DEPARTMENT OF MICROBIOLOGY AND IMMUNOLOGY THE INSTITUTE OF MEDICAL SCIENCE, THE UNIVERSITY OF TOKYO (Japan))
[P-13]Ex vivo organ culture approach for comparative analysis of the tick susceptibility to an emerging tick-borne bunyavirus identified a potential vector tick species
*Keita Mizuma1, Samuel Kelava4, Maria Angenica F. Regilme2, Yurie Taya2,7, Yume Mimura2, Yuma Ohari2, Ryo Nakao4, Keita Matsuno2,3,5,6 (1. Department of GMP Education and Immunology, The UTOPIA Center, The University of Tokyo (Japan), 2. Division of Risk Analysis and Management, International Institute for Zoonosis Control, Hokkaido University (Japan), 3. One Health Research Center, Hokkaido University (Japan), 4. Laboratory of Parasitology, Graduate School of Infectious Diseases, Faculty of Veterinary Medicine, Hokkaido University, (Japan), 5. International Collaboration Unit, International Institute for Zoonosis Control, Hokkaido University, (Japan), 6. Institute for Vaccine Research and Development (HU-IVReD), Hokkaido University (Japan), 7. Institute for Integrated Innovations & Faculty of Health Sciences, Hokkaido University (Japan))
[P-15]Development of a Multi-Point-Binding Virus Binder Designed Using Machine Learning
*Kazuhito Tabata1 (1. Research Institute of Planetary Health, The University of Tokyo (Japan))
[P-17]Neonatal systemic AAV9 administration is associated with genome-dependent cardiac inflammation and fibrosis in mice
*Hiroshi Ueki1,2, Yuji Tsunekawa3, Mikako Wada3, Ken Sugo3, Azusa Onodera3, Kiyoko Iwatsuki-Horimoto1,6, Hiromi Hayashita-Kinoh3, Yuri Furusawa1,6, Yoshihiro Kawaoka1,2,4,6,5, Seiya Yamayoshi1,2,5,6, Takashi Okada3 (1. Department of Virology, The UTOPIA Center, The University of Tokyo (Japan), 2. The Research Center for Global Viral Diseases, National Institute of Global Health and Medicine, Japan Institute for Health Security (Japan), 3. Division of Molecular and Medical Genetics, Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo (Japan), 4. Department of Pathobiological Sciences, School of Veterinary Medicine, University of Wisconsin-Madison (USA), 5. Department of Special Pathogens, International Research Center for Infectious Diseases, Institute of Medical Science, University of Tokyo (Japan), 6. Division of Virology, Institute of Medical Science, University of Tokyo (Japan))
[P-19]Functional Characterization of DENV1 Full-Length Clones Bearing Insect-Specific Envelope Fusion Loop Mutations
*Irish Coleen Angelo Asin1, Adeline Yeo Syin Lian1, Kazumi Haga1, Meng Ling Moi1,2 (1. School of International Health, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-0033 (Japan), 2. The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), Tokyo (Japan))
[P-21]Phage display derived human monoclonal antibodies targeting consensus envelope domain III of dengue virus
*Sabita Prajapati1,2, Chetana Khanal3, Kazumi Haga1, Adeline Yeo Syin Lian1, Sujan Shresta4, Meng Ling Moi1,5, Montarop Yamabhai2 (1. School of International Health, Graduate School of Medicine, The University of Tokyo, Tokyo, 113-0033 (Japan), 2. School of Biotechnology, Institute of Agricultural Technology, Suranaree University of Technology, Suranaree, Muang, Nakhon Ratchasima (Thailand), 3. Translational Medicine, Institute of Medicine, Suranaree University of Technology, Suranaree, Muang, Nakhon Ratchasima (Thailand), 4. Center for Infectious Disease and Vaccine research, La Jolla Institute for Immunology, 9420 Athena Circle, La Jolla, CA (USA), 5. The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), Tokyo (Japan))
[P-23]Dimeric Fusion Loop Aptamers as Broad-Spectrum Neutralizing Candidates Against Dengue Virus Serotypes 1–4
*Islam Bakhrom Karimov1, Adeline Yeo Syin Lian1, Ryo Amano2, Kazumi Haga1, Masaki Takahashi3, Meng Ling Moi1,4 (1. Department of Developmental Medical Sciences, School of International Health, Graduate School of Medicine, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan. (Japan), 2. National Institute of Infectious Diseases (NIID) (Japan), 3. RIBOMIC Inc., Minato-ku, Tokyo 108-0071, Japan (Japan), 4. The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), Tokyo, Japan (Japan))
[P-25]Elucidation of the nuclear pore complex in parasitic protists
*Huda Amilina1, Herbert J. Santos1, Tomoyoshi Nozaki1 (1. Department of Biomedical Chemistry, Graduate School of Medicine, The University of Tokyo (Japan))
[P-27]Detection of Bordetella spp. in wastewater for exploring its potential in public health surveillance
*Ryota Gomi1, Kotomi Yoshida1, Vu Duc Canh2, Hiroyuki Katayama1, Masaaki Kitajima1,3 (1. Research Center for Water Environment Technology, School of Engineering, The University of Tokyo (Japan), 2. Faculty of Environment and Labour Safety, Ton Duc Thang University (Viet Nam), 3. The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo (Japan))
[P-29]Non-invasive viral surveillance for monitoring emerging infectious diseases in cetaceans
*Wataru Sekine1, Masaaki Kitajima2, Takeru Tsunoi3, Junna Kawasaki3,4, Sho Miyamoto3, Misa Katayama1, Ayano Ichikawa1, Yuta Wakabayashi1, Akiko Uema1, Shin Murakami1, Taisuke Horimoto1 (1. Department of Veterinary Medical Science, The University of Tokyo (Japan), 2. Research Center for Water Environment Technology, School of Engineering, The University of Tokyo (Japan), 3. Laboratory of Infectious Disease Pathobiology, Chiba University (Japan), 4. Bioinformatics center, The University of Osaka (Japan))
[P-31]Pertussis Toxin IgG Seropositivity During the 2025 Outbreak: A Comparison Between People With HIV and Without HIV
Aiko Okazkai1, *Michiko Koga1, Akari Fukuda2, Natsuko Kubo2, Naoko Nishiyama2, Aya Ishizaka3, Etsuko Nagai2, Wakana Sato2, Yukiko Taguchi2, Hiroki Abe2, Hironori Shimosaka2, Yoshiaki Kanno2, Eisuke Adachi2, Tokiko Nagamura2, Hiroshi Yotsuyanagi3 (1. Department of Infectious Diseases, The UTOPIA Center, The University of Tokyo (Japan), 2. The Institute of Medical Science, The University of Tokyo (Japan), 3. Japan Institute for Health Security (Japan))
[P-33]Clinical Features and Molecular Characteristics of Bunyaviricetes
*Fatihan Pinarlik1,2,3, Önder Ergönül4,5, Ken Ishii2,3,6, Cevayir Coban1,2,3 (1. Division of Malaria Immunology, Department of Microbiology and Immunology, Institute of Medical Science, The University of Tokyo (Japan), 2. International Vaccine Design Center, The Institute of Medical Science, The University of Tokyo, Tokyo (Japan), 3. The University of Tokyo Pandemic Preparedness, Infection and Advanced Research Center (UTOPIA), The University of Tokyo, Tokyo (Japan), 4. Koç University School of Medicine, Infectious Diseases and Clinical Microbiology, Istanbul (Turkey), 5. Koc University Isbank Center for Infectious Diseases, Koc University, Istanbul (Turkey), 6. Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo (Japan))
[P-35]Development of IL-12-expressing HSV-1 for malignant melanoma
*Hitomi Nakamura1,2, Miwako Iwai1, Ryuhei Okuyama2, Tomoki Todo1 (1. Project Division of Oncolytic Virus Development, The Institute of Medical Science, The University of Tokyo (Japan), 2. The Department of Dermatology, Shinshu University School of Medicine (Japan))
[P-37]Human lung organoid-based analysis of respiratory syncytial virus infection
*Rina Hashimoto1, Yuki Kitai2, Masaya Sugiyama3, Takuya Yamamoto4, Miki Nagao5, Makoto Takeda2, Kazuo Takayama1 (1. Medical Research Laboratory, Institute of Integrated Research, Institute of Science Tokyo (Japan), 2. Department of Microbiology, Graduate School of Medicine and Faculty of Medicine, The University of Tokyo (Japan), 3. Department of Viral Pathogenesis and Controls, National Institute of Global Health and Medicine, Japan Institute for Health and Security (Japan), 4. Center for iPS Cell Research and Application (CiRA), Kyoto University (Japan), 5. Department of Clinical Laboratory Medicine, Graduate School of Medicine, Kyoto University (Japan))
[P-39]Development of a Sybody Screening Method Using Viruses as Antigens
*Tatsuki Tanaka1, Shinichiro Aiba1, Osamu Nureki1 (1. Department of Biological Sciences, Graduate School of Science, The University of Tokyo (Japan))
[P-41]Parallel ZNF598 and GIGYF2 pathways mediate conserved collision-dependent mRNA decay with distinct endonucleolytic features
*Satoshi Hashimoto1, Jennifer SAUERLAND1,2,3, Jiahuan ZENG1, Chisato Kikuguchi1, Toshifumi INADA1 (1. Division of RNA and Gene Regulation The Institute of Medical Science, The University of Tokyo (Japan), 2. Max Planck Institute of Biochemistry (Germany), 3. Gene Center and Department of Biochemistry, Faculty of Chemistry and Pharmacy, Ludwig Maximilian University of Munich (Germany))
[P-43]Control of Melanoma Lung Metastasis Through Partial Reprogramming of Alveolar Macrophages
*Akihiko Sugimoto1, Sho Ohta1, Fumie Nakasuka1, Yasuhiro Yamada1 (1. Department of Molecular Pathology, Graduate School of Medicine, The University of Tokyo (Japan))
[P-45]Visualizing co-translational assembly of translation factor eIF2B subunits at the single-mRNA level in live cells
*Hayato Ito1,2, Tatsuya Morisaki4, Timothy J Stasevich4, Hideki Taguchi3, Hotaka Kobayashi1,2 (1. IQB, The University of Tokyo (Japan), 2. IAMS, Tokushima University (Japan), 3. IIR, Institute of Science Tokyo (Japan), 4. Dept. BMB, Colorado State University (USA))
[P-47]Polycomb Repressive Complex 1.1 restrains inflammation-induced myeloid cell death
*Yaeko Nakajima-Takagi1, Takanori Fukuta1, Atsushi Iwama1 (1. Division of Stem Cell and Molecular Medicine, Institute of Medical Science, The University of Tokyo (Japan))
[P-49]De novo design of protein inhibitors for ENPP1, a nucleotide hydrolase
*Ryota Hirabayashi1, Keitaro Yamashita1,2, Masahiro Hiraizumi1,2, Hiroshi Nishimasu1,2 (1. Department of Chemistry and Biotechnology, Study of Engineering, The University of Tokyo (Japan), 2. Research Center for Advanced Science and Technology, The University of Tokyo (Japan))
[P-51]confidential
*Ryuta Kanai1 (1. Laboratory of Membrane Proteins, Institute for Quantitative Biosciences, The University of Tokyo (Japan))
[P-53]Structural basis for high-affinity target recognition by unnatural base-containing DNA aptamers
*Tsukasa Kusakizako1, Kazuhiro Sawada1, Osamu Nureki1 (1. Department of Biological Sciences, Graduate School of Science, The University of Tokyo (Japan))
[P-55]Structural biology approach to infectious diseases
*Yoshiaki Kise1, Kazuhiro Sawada1, Kanata Matsumoto1, Hana Matsushita1, Shin Mukai1, Osamu Nureki1 (1. Department of Biological Sciences, The University of Tokyo (Japan))
[P-57]Remote robotic animal experimentation enables low-exposure workflows with preserved performance
*Tomoya Hayashi1, Noritake Kikunishi1,2, Kiyoko Iwatsuki-Horimoto1, Kazunori Sasaki1, Ayane Takao1, Asuka Joy Tobuse1, Mai Onaga1, Sean Lord Irish1, Koki Uotani1, Burcu Temizoz1, Hideo Negishi1, Misako Nakayama1, Naoki Sakuyama1, Junko Mukohyama1, Go Ito1, Tetsukan Woo2, Aya Saito2, Takeshi Inoue3, Cevayir Coban1,3, Dai Shida1, Junichiro Inoue3, Yoshihiro Kawaoka1,3, Kouji Kobiyama4, Ken J Ishii1,3 (1. The Institute of Medical Science, The University of Tokyo (Japan), 2. Yokohama City University (Japan), 3. The UTOPIA Center, The University of Tokyo (Japan), 4. University of California San Diego (USA))
[P-59]Contact Heterogeneity Using Multimodal Big Data and Deep Generative Models
*Daisuke Yoneoka1 (1. Graduate School of Medicine, The University of Tokyo (Japan))
[P-61]Toward Improved Influenza Strain Prediction Using HA Structural Modeling and Glycan Shielding Analysis.
*Tetsutaro Kimihira1, Jumpei Ukita1, Yutaka Matsuo1 (1. Matsuo-Iwasawa lab, Graduate School of Engineering, The University of Tokyo (Japan))
[P-63]New High-Efficiency Aseptic Filling System for Investigational Drugs developed by UTOPIA - Contributing to the Early Transition from Basic Research to Clinical Development -
*Norihiro Nishimoto1 (1. The UTOPIA Center, The University of Tokyo (Japan))